日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Basal-shift transformation leads to EGFR therapy-resistance in human lung adenocarcinoma.

基底移位转化导致人类肺腺癌对 EGFR 疗法产生耐药性

Shinozaki Taro, Togasaki Kazuhiro, Hamamoto Junko, Mitsuishi Akifumi, Fukushima Takahiro, Sugihara Kai, Ebisudani Toshiki, Okada Masahiko, Saito Ayaka, Shigematsu Lisa, Takaoka Hatsuyo, Ito Fumimaro, Ohgino Keiko, Ishioka Kota, Watanabe Kageaki, Hishima Tsunekazu, Kurebayashi Yutaka, Emoto Katsura, Terai Hideki, Ikemura Shinnosuke, Kawada Ichiro, Asakura Keisuke, Hishida Tomoyuki, Asamura Hisao, Ohta Yuki, Takahashi Sirirat, Oda Mayumi, Saito Megumu, Matano Mami, Soejima Kenzo, Fujii Masayuki, Fukunaga Koichi, Yasuda Hiroyuki, Sato Toshiro

Inhibiting KRAS with CD47 and immune checkpoint overcomes intrinsic resistance to combined KRAS and immune checkpoint inhibitor therapy

利用 CD47 和免疫检查点抑制剂抑制 KRAS 可克服对 KRAS 和免疫检查点抑制剂联合疗法的内在耐药性。

Kentaro Hirade,Noritaka Tanaka,Taisuke Kajino,Yuta Adachi,Ryo Kimura,Hitomi Kasuya,Satoru Kisoda,Tze King Tan,Sho Hayakawa,Takahiko Sato,Shogo Yanase,Yoko Kitaura,Takamasa Yamamoto,Yuki Nishioka,Osamu Muto,Daisuke Muraoka,Teruaki Fujishita,Natsumi Kasuga,Kageaki Watanabe,Yoshihiko Sakata,Masahiro Aoki,Hirokazu Matsushita,Takaomi Sanda,Shinsuke Iida,Kohsuke Tsuchiya,Rui Yamaguchi,Hiromichi Ebi

Plasma cell-free DNA methylation profile before afatinib treatment is associated with progression-free and overall survival of patients with epidermal growth factor receptor gene mutation-positive non-small cell lung cancer

阿法替尼治疗前血浆游离DNA甲基化谱与表皮生长因子受体基因突变阳性非小细胞肺癌患者的无进展生存期和总生存期相关

Fujimoto, Mao; Yasuda, Hiroyuki; Arai, Eri; Nakajima, Makoto; Takata, Saori; Morikawa, Kei; Tanaka, Hisashi; Itani, Hidetoshi; Honda, Takeshi; Horiuchi, Kazuya; Watanabe, Kageaki; Nakagawa, Hideyuki; Nakahara, Yoshiro; Seki, Yoshitaka; Bessho, Akihiro; Takahashi, Nobumasa; Hayashi, Kentaro; Endo, Takeo; Takeyama, Kiyoshi; Maekura, Toshiya; Takigawa, Nagio; Kawase, Akikazu; Endoh, Makoto; Nemoto, Kenji; Kishi, Kazuma; Soejima, Kenzo; Okuma, Yusuke; Togashi, Akira; Matsutani, Noriyuki; Seki, Nobuhiko; Kanai, Yae

Efficacy of EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer with EGFR exon 19 insertions: clinical-genomic, preclinical analysis through LC-SCRUM-Asia (multi-institutional genomic screening registry)

EGFR酪氨酸激酶抑制剂对EGFR 19号外显子插入的非小细胞肺癌患者的疗效:通过LC-SCRUM-Asia(多机构基因组筛查登记)进行的临床基因组学和临床前分析

Uehara, Yuji; Izumi, Hiroki; Kobayashi, Ikei S; Matsumoto, Shingo; Hosomi, Yukio; Okuno, Takae; Sugisaka, Jun; Takase, Naoto; Taima, Kageaki; Sasaki, Shinichi; Teranishi, Shuhei; Miyamoto, Shingo; Mori, Masahide; Nakashima, Chiho; Asano, Shuichi; Oi, Hajime; Sakai, Tetsuya; Shibata, Yuji; Udagawa, Hibiki; Sugiyama, Eri; Nosaki, Kaname; Umemura, Shigeki; Zenke, Yoshitaka; Yoh, Kiyotaka; Ikeda, Sadakatsu; Costa, Daniel B; Kobayashi, Susumu S; Goto, Koichi

ROS-Driven PKCζ Signaling as a Widely Involved Mechanism for Cancer Cell Motility and Metastasis

ROS驱动的PKCζ信号通路是癌细胞运动和转移的广泛参与机制

Sato, Yasushi; Tanaka, Maki; Kitamura, Naoko; Araki, Naoko; Kurata, Wataru; Sasaki, Akiko; Seo, Yukimi; Kuribayashi, Kageaki; Kobayashi, Shuzo; Niitsu, Yoshiro

The gut microbiota as a potential biomarker in patients with EGFR-mutant lung cancer

肠道菌群作为EGFR突变型肺癌患者的潜在生物标志物

Tabe, Chiori; Motooka, Daisuke; Fujita, Toshitsugu; Makiguchi, Tomonori; Taima, Kageaki; Tanaka, Hisashi; Itoga, Masamichi; Ishioka, Yoshiko; Akita, Takahiro; Ishidoya, Mina; Chubachi, Kei; Fukushima, Takashi; Tanaka, Yusuke; Odagiri, Haruka; Kameyama, Yuko; Kobori, Yuri; Tasaka, Sadatomo; Fujii, Hodaka

Single-arm multicenter phase II study on aggressive local consolidative therapy in combination with systemic chemotherapy for stage IV non-small cell lung carcinoma with oligometastases: CURE-OLIGO (TORG1529)

一项针对伴有寡转移的 IV 期非小细胞肺癌的积极局部巩固治疗联合全身化疗的单臂多中心 II 期研究:CURE-OLIGO (TORG1529)

Tokito, Takaaki; Yamada, Kazuhiko; Ishii, Hidenobu; Takiguchi, Yuichi; Saito, Go; Minato, Koichi; Imai, Hisao; Tanaka, Hiroshi; Miura, Satoru; Watanabe, Kageaki; Koreeda, Yoshifusa; Ono, Akira; Furuya, Naoki; Misumi, Toshihiro; Hayakawa, Kazushige; Ogo, Etsuyo; Okamoto, Hiroaki

PD-L1 expression on tumor cells and tumor-infiltrating immune cells in thymic epithelial tumors detected with SP142 and SP263 antibodies

使用 SP142 和 SP263 抗体检测胸腺上皮肿瘤中肿瘤细胞和肿瘤浸润免疫细胞上的 PD-L1 表达

Chubachi, Kei; Tanaka, Hisashi; Taima, Kageaki; Tasaka, Sadatomo; Kurose, Akira

Real-World Study of EGFR-TKI Rechallenge With Another TKI After First-Line Osimertinib Discontinuation in Patients With EGFR-Mutated Non-Small Cell Lung Cancer: A Subset Analysis of the Reiwa Study

一项真实世界研究评估了EGFR突变型非小细胞肺癌患者一线奥希替尼停药后再次使用另一种TKI治疗的疗效:令和研究的子集分析

Sonehara, Kei; Tateishi, Kazunari; Yoh, Kiyotaka; Usui, Kazuhiro; Hosomi, Yukio; Kishi, Kazuma; Naka, Go; Watanabe, Kageaki; Tamano, Shu; Uemura, Kohei; Kunitoh, Hideo

Association Between Baseline Neutrophil Count and Febrile Neutropenia Following Docetaxel and Ramucirumab With Prophylactic Pegfilgrastim

多西他赛和雷莫芦单抗联合预防性培非格司亭治疗后,基线中性粒细胞计数与发热性中性粒细胞减少症之间的关联

Makiguchi, Tomonori; Odagiri, Haruka; Tanaka, Hisashi; Taima, Kageaki; Tasaka, Sadatomo